Topic

Orfadin (nitisinone)

A collection of 13 issues

How to Get Orfadin (nitisinone) Covered by Cigna in Michigan: Complete 2025 Guide to Prior Authorization, Appeals & Timelines

Quick Answer: To get Orfadin (nitisinone) covered by Cigna in Michigan, you need prior authorization with confirmed hereditary tyrosinemia type 1 diagnosis (ICD-10 E70.29), elevated succinylacetone labs, and a documented dietary management plan restricting tyrosine/phenylalanine. Standard approval takes up to 5 business days; expedited reviews within 24-72 hours.

How to Get Orfadin (nitisinone) Covered by Blue Cross Blue Shield in New Jersey: Complete Guide to Prior Authorization and Appeals

Answer Box: Getting Orfadin Covered by Blue Cross Blue Shield in New Jersey Orfadin (nitisinone) requires prior authorization from Blue Cross Blue Shield in New Jersey. To get approved: (1) Confirm your HT-1 diagnosis with elevated succinylacetone levels and genetic testing, (2) Have your specialist submit a prior authorization request

Getting Orfadin (Nitisinone) Covered by Cigna in New York: Coding, Appeals & Prior Authorization Guide

Answer Box: Getting Orfadin (Nitisinone) Covered by Cigna in New York Orfadin (nitisinone) for hereditary tyrosinemia type 1 requires Cigna prior authorization using ICD-10 code E70.29 and HCPCS J8499. Key steps: 1) Confirm HT-1 diagnosis with elevated succinylacetone levels, 2) Submit PA with specialist documentation and dietary management plan,